Navigation Links
The first impact factor for PLoS Biology ?13.9

The open-access journal PLoS Biology has been assessed by Thomson ISI to have an impact factor of 13.9*, which places PLoS Biology among the most highly cited journals in the life sciences. This is an outstanding statistic for a journal less than two years old, from a new publisher promoting a new business model that supports open access to the scientific and medical literature.

An impact factor of 13.9 places PLoS Biology above such established journals as EMBO Journal, Current Biology, and the Proceedings of the National Academy of Sciences. In fact, in ISI's category of general biology journals, PLoS Biology is ranked number 1.

PLoS Biology was launched in October 2003, as an open-access home to the very best in biological research. By any measure, the impact of this launch was impressive. The on-line publication of the first issue was accompanied by strong and favorable media coverage, and subsequent issues continue to receive regular attention. Content from PLoS Biology has been read, copied, redistributed, and reused, without restriction (aside from proper citation of the authors), and now we know that the journal has also been cited time and time again.

PLoS Biology was launched to provide biologists who support open access a high profile journal for their best research papers and to demonstrate that open-access publishing works for a selective journal that only publishes outstanding science. Thanks to support from funding agencies, librarians, open-access advocates, and the scientific community ?in particular, the editorial board members of PLoS Biology, the reviewers, and most of all the authors who have submitted excellent work to a fledgling journal ?a substantial step has been taken toward these goals.

But there is still a long way to go before the mission of the Public Library of Science ?to make the world's treasury of scientific and medical literature a public resource ?is fulfilled. We hope that PLoS Biology's first imp act factor will inspire even greater support for PLoS journals and for open access.

* Thomson ISI calculated the impact factors that it announced this year by counting all the citations in 2004 to content that appeared in 2002 and 2003 and then dividing that number by the number of articles published in 2002 and 2003. For a long-standing journal, therefore, this number reflects the mean (average) number of citations over the course of a year to articles published over the two prior years. For PLoS Biology, this number refers only to articles published in its first three issues in the fall of 2003, which is why the initial impact factor is considered preliminary.


Source:Public Library of Science

Related biology news :

1. A genes first kiss sets off that affair known as puberty
2. Love at first smell
3. Worlds largest rainforest drying experiment completes first phase
4. PCRM develops worlds first cruelty-free insulin assay
5. Expression Project for Oncology (expO) completes first phase of standardized gene expression analyses
6. World-first Living Donor Islet Cell Transplant A Success; Procedure Offers Promise For Diabetics
7. DuPonts first biologically derived polymer receives global recognition
8. Anti cancer virotherapy well tolerated in first human administration, research finds
9. Unlike other mammals, newborn dolphins and orcas stay active 24/7 during first months of development
10. Moffitt-USF head toward first human trials of anti-cancer drug that targets protein AKT
11. Researchers find first evidence of venom system in extinct mammal
Post Your Comments:

(Date:11/9/2015)... , Nov. 9, 2015  Synaptics Inc. (NASDAQ: ... today announced broader entry into the automotive market with ... match the pace of consumer electronics human interface innovation. ... are ideal for the automotive industry and will be ... Europe , Japan ...
(Date:11/2/2015)... MENLO PARK, Calif. , Nov. 2, 2015 /PRNewswire/ ... to $9 million to provide preclinical development services to ... Under the contract, SRI will provide scientific expertise, modern ... a wide variety of preclinical pharmacology and toxicology studies ... --> --> The PREVENT Cancer Drug ...
(Date:10/29/2015)... Calif. , Oct. 29, 2015  The J. ... new report titled, "DNA Synthesis and Biosecurity: Lessons Learned ... the Department of Health and Human Services guidance for ... in 2010. --> ... it also has the potential to pose unique biosecurity ...
Breaking Biology News(10 mins):
(Date:11/30/2015)... and MAGDEBURG, Germany , November 30, ... (ECNR) in Vienna, Austria to ... Congress of NeuroRehabilitation (ECNR) in Vienna, Austria ... NovaVision, a wholly owned subsidiary of Vycor Medical, Inc. ... of its Internet-delivered NovaVision Therapy Suite at the 3rd ...
(Date:11/28/2015)... ... 2015 , ... • Jeon Jin Bio Corp, a Korean Biotech venture company, ... , Bird Free, an oil-based, gel formula made ... including visual, smell, taste and touch, enabling safe, effective avian control without toxic chemicals ...
(Date:11/26/2015)... 2015 ... Research Laboratories, a leading independent and ... has formed a strategic partnership with ... Health for joint work on clinical ... ) , --> ,     ...
(Date:11/25/2015)... 25, 2015 2 nouvelles études permettent ... les différences entre les souches bactériennes retrouvées dans la ... des êtres humains . Ces recherches  ouvrent une nouvelle ... prise en charge efficace de l,un des problèmes ... chats .    --> 2 nouvelles études ...
Breaking Biology Technology: